Main > ONCOLOGY (**) > Breast Cancer>HER2+>Adjuvant *** > USA. G. PertuzuMAb+TrastuzuMAb+ IV > (*) USA Approval Date: 2017. 12.20.

---

(*) USA Approval Date: 2017. 12.20.'s products
This section has no products